Document Detail


The effects of glutamine-supplemented parenteral nutrition in premature infants.
MedLine Citation:
PMID:  8788268     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Glutamine (GLN) is the primary fuel for rapidly dividing cells, yet it is not a constituent of parenteral nutritional formulas administered to newborns. The aims of this prospective, randomized, double-blind trial were (1) to confirm the safety of glutamine supplementation for premature infants and (2) to examine the effects of glutamine-supplemented parenteral nutrition on length of stay, days on total parenteral nutrition (TPN), days on the ventilator, and other clinical outcomes. METHODS: Premature infants received either standard or glutamine-supplemented TPN and were monitored throughout length of stay for various health and biochemical indices. The group was examined as a whole (n = 44; birth weight range: 530 to 1250 g) and in two weight subgroups, < 800 and > or = 800 g. RESULTS: Serum ammonia, blood urea nitrogen, and glutamate tended to be higher in the GLN groups, but the levels were well within normal limits. In the < 800-g cohort (n = 24), glutamine-supplemented infants required fewer days on TPN (13 vs 21 days, p = .02), had a shorter length of time to full feeds (8 vs 14 days, p = .03), and needed less time on the ventilator (38 vs 47 days, p = .04). There was a tendency toward a shorter length of stay in the NICU (73 vs 90 days, NS). These findings were not observed in the infants > or = 800 g (n = 20). CONCLUSIONS: Glutamine appears to be safe for use in premature infants and seems to be conditionally essential in premature infants with extremely low birth weights. Larger multicenter trials are needed to confirm these observations and further evaluate the efficacy of GLN in these high-risk premature infants.
Authors:
J M Lacey; J B Crouch; K Benfell; S A Ringer; C K Wilmore; D Maguire; D W Wilmore
Related Documents :
25041388 - Tuning the developing brain to emotional body expressions.
3087658 - Biochemical markers in the assessment of protein-calorie malnutrition in premature neon...
8788268 - The effects of glutamine-supplemented parenteral nutrition in premature infants.
476208 - Assessment of ventilation-perfusion inequality by aadn2 in newborn infants.
23975948 - Cortical activation to action perception is associated with action production abilities...
18515298 - Prefrontal activation associated with social attachment: facial-emotion recognition in ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JPEN. Journal of parenteral and enteral nutrition     Volume:  20     ISSN:  0148-6071     ISO Abbreviation:  JPEN J Parenter Enteral Nutr     Publication Date:    1996 Jan-Feb
Date Detail:
Created Date:  1996-10-18     Completed Date:  1996-10-18     Revised Date:  2007-02-21    
Medline Journal Info:
Nlm Unique ID:  7804134     Medline TA:  JPEN J Parenter Enteral Nutr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  74-80     Citation Subset:  IM    
Affiliation:
Laboratory for Surgical Metabolism and Nutrition, Brigham and Women's Hospital, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Birth Weight
Blood Urea Nitrogen
Double-Blind Method
Female
Gestational Age
Glutamic Acid / blood
Glutamine / administration & dosage*,  blood
Humans
Infant, Newborn
Infant, Premature*
Male
Parenteral Nutrition, Total*
Prospective Studies
Chemical
Reg. No./Substance:
56-85-9/Glutamine; 56-86-0/Glutamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early enteral feeding in the pediatric intensive care unit.
Next Document:  Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution.